第一单位：
Cancer Prognostics and Health Outcomes Unit, Department of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Division of Experimental Oncology/Departmen of Urology, URI; IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: deangelis.mario@hsr.it.
作者：
Mario,de Angelis [1]
;
Lukas,Scheipner [2]
;
Carolin,Siech [3]
;
Letizia Maria Ippolita,Jannello [4]
;
Andrea,Baudo [5]
;
Francesco Di,Bello [6]
;
Jordan A,Goyal [7]
;
Kira,Vitucci [3]
;
Zhe,Tian [7]
;
Nicola,Longo [8]
;
Sascha,Ahyai [9]
;
Ottavio,de Cobelli [10]
;
Felix K H,Chun [11]
;
Fred,Saad [7]
;
Shahrokh F,Shariat [12]
;
Luca,Carmignani [13]
;
Giorgio,Gandaglia [14]
;
Marco,Moschini [14]
;
Francesco,Montorsi [14]
;
Alberto,Briganti [14]
;
Pierre I,Karakiewicz [7]
作者单位：
Cancer Prognostics and Health Outcomes Unit, Department of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Division of Experimental Oncology/Departmen of Urology, URI; IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: deangelis.mario@hsr.it.
[1]
Cancer Prognostics and Health Outcomes Unit, Department of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, Medical University of Graz, Graz, Austria.
[2]
Cancer Prognostics and Health Outcomes Unit, Department of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.
[3]
Cancer Prognostics and Health Outcomes Unit, Department of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
[4]
Cancer Prognostics and Health Outcomes Unit, Department of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, IRCCS Policlinico San Donato, Milan, Italy.
[5]
Cancer Prognostics and Health Outcomes Unit, Department of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, University Hospital, Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.
[6]
Cancer Prognostics and Health Outcomes Unit, Department of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
[7]
Department of Urology, University Hospital, Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.
[8]
Department of Urology, Medical University of Graz, Graz, Austria.
[9]
Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
[10]
Department of Urology, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.
[11]
Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Hourani Center of Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
[12]
Department of Urology, IRCCS Policlinico San Donato, Milan, Italy.
[13]
Division of Experimental Oncology/Departmen of Urology, URI; IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
[14]
DOI
10.1016/j.clgc.2024.102119
PMID
38852435
发布时间
2026-06-29
换一批
